Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
life sciences
national
5
×
national blog main
bristol-myers squibb
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
esmo
european society for medical oncology
fda
immunotherapy
keytruda
larotrectinib
loxo oncology
merck
mirati therapeutics
What
clinical
5
×
medical
annual
cancer
oncology
society
acquisition
anniversary
approaches
bn
bristol
celgene
chief
company’s
conference
corporation
diversity
esmo
european
hirawat
meeting
myers
myers’s
officer
pipeline
progress
scrip
spoke
squibb
today
trial
year
ahead
ambien
american
asco
ash
attendees
attention
barcelona
Language
unset
Current search:
clinical
×
national
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
